EU nod for Merck’s MS therapy Mavenclad
admin 25th August 2017 Uncategorised 0Merck’s Mavenclad has bagged approval in the European Union, Norway, Liechtenstein and Iceland to treat highly active relapsing multiple sclerosis.
More: EU nod for Merck’s MS therapy Mavenclad
Source: News